NO20060964L - Farmasoytiske sammensetninger med midifisert frigjoring av modafinil - Google Patents

Farmasoytiske sammensetninger med midifisert frigjoring av modafinil

Info

Publication number: NO20060964L
Authority: NO; Norway
Prior art keywords: modafinil; pharmaceutical compositions; modified release; pharmaceutical; traditional
Prior art date: 2003-09-18

Application number

NO20060964A

Other languages

English (en)

Norwegian (no)

Inventor

Piyush R Patel

Alpa Parikh

Original Assignee

Cephalon Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-09-18

Filing date

2006-02-28

Publication date

2006-04-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34381093&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20060964(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-02-28 Application filed by Cephalon Inc filed Critical Cephalon Inc

2006-04-18 Publication of NO20060964L publication Critical patent/NO20060964L/no

Links

YFGHCGITMMYXAQ-UHFFFAOYSA-N 2-[(diphenylmethyl)sulfinyl]acetamide Chemical compound C=1C=CC=CC=1C(S(=O)CC(=O)N)C1=CC=CC=C1 YFGHCGITMMYXAQ-UHFFFAOYSA-N 0.000 title abstract 3
229960001165 modafinil Drugs 0.000 title abstract 3
239000008194 pharmaceutical composition Substances 0.000 title abstract 3
239000000825 pharmaceutical preparation Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

NO20060964A 2003-09-18 2006-02-28 Farmasoytiske sammensetninger med midifisert frigjoring av modafinil NO20060964L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US50402803P	2003-09-18	2003-09-18
US10/944,528 US8153159B2 (en)	2003-09-18	2004-09-17	Modafinil modified release pharmaceutical compositions
PCT/US2004/030815 WO2005027890A1 (en)	2003-09-18	2004-09-20	Modafinil modified release pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
NO20060964L true NO20060964L (no)	2006-04-18

Family

ID=34381093

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20060964A NO20060964L (no)	2003-09-18	2006-02-28	Farmasoytiske sammensetninger med midifisert frigjoring av modafinil

Country Status (20)

Country	Link
US (1)	US8153159B2 (de)
EP (1)	EP1670447B1 (de)
JP (1)	JP5138932B2 (de)
KR (1)	KR20060117910A (de)
AR (1)	AR046410A1 (de)
AT (1)	ATE448780T1 (de)
AU (1)	AU2004274017B2 (de)
BR (1)	BRPI0414299A (de)
CA (1)	CA2536666C (de)
DE (1)	DE602004024220D1 (de)
EA (1)	EA011400B1 (de)
ES (1)	ES2336215T3 (de)
IL (1)	IL173738A (de)
IS (1)	IS2787B (de)
MX (1)	MXPA06003125A (de)
MY (1)	MY144755A (de)
NO (1)	NO20060964L (de)
NZ (1)	NZ545573A (de)
TW (1)	TWI344840B (de)
WO (1)	WO2005027890A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1126826T6 (en) *	1998-11-02	2019-06-24	Alkermes Pharma Ireland Ltd	Multiparticulate modified release of methylphenidate
WO2005117585A1 (en) *	2004-05-28	2005-12-15	Transform Pharmaceuticals, Inc.	Mixed co-crystals and pharmaceutical compositions comprising the same
US20060121112A1 (en) *	2004-12-08	2006-06-08	Elan Corporation, Plc	Topiramate pharmaceutical composition
WO2007037790A2 (en) *	2005-06-08	2007-04-05	Elan Corporation, Plc	Modified release famciclovir compositions
KR20080095873A (ko)	2006-02-13	2008-10-29	반다 파마슈티칼즈, 인코퍼레이티드.	이미다졸릴알킬-피리딘의 안정한 제제
MX2009000391A (es) *	2006-07-12	2009-06-30	Elan Pharma Int Ltd	Formulación de modafinilo en forma de nano-partículas.
DE102006035549A1 (de) *	2006-07-27	2008-01-31	Evonik Röhm Gmbh	Arzneiform mit mindestens zweischichtiger Trennschicht
US20090082461A1 (en) *	2007-09-25	2009-03-26	Protia, Llc	Deuterium-enriched modafinil
JP5250285B2 (ja) *	2008-03-26	2013-07-31	富士フイルム株式会社	経口物用被覆材、可食性容器およびそれらを用いた経口物
WO2010012407A1 (en) *	2008-07-29	2010-02-04	Ashland Licensing And Intellectual Property Llc.	Modified additives for suppressing dust formation
KR101465077B1 (ko) *	2010-07-06	2014-11-26	주식회사 네비팜	다폭세틴을 포함하는 시간차 서방출 경구투여형 약학적 조성물
US8999393B1 (en) *	2013-01-09	2015-04-07	Edgemont Pharmaceuticals Llc	Sustained release formulations of lorazepam
PL3137060T5 (pl)	2014-05-01	2024-04-08	Sun Pharmaceutical Industries Ltd	Kompozycje zawiesinowe o przedłużonym uwalnianiu
CA2999990A1 (en)	2015-09-29	2017-04-06	Acorda Therapeutics, Inc.	Sustained release compositions of 4-aminopyridine
CA3069563A1 (en) *	2017-07-10	2019-01-17	Takeda Pharmaceutical Company Limited	Preparation comprising vonoprazan

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5534263A (en) *	1995-02-24	1996-07-09	Alza Corporation	Active agent dosage form comprising a matrix and at least two insoluble bands
US6346548B1 (en) *	1999-08-16	2002-02-12	Cephalon, Inc.	Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
US6627223B2 (en) *	2000-02-11	2003-09-30	Eurand Pharmaceuticals Ltd.	Timed pulsatile drug delivery systems
US6458384B2 (en)	2000-02-23	2002-10-01	Impetus Ag	Pharmaceutical with predetermined activity profile
US6492396B2 (en)	2000-05-16	2002-12-10	Cephalon, Inc.	Substituted thioacetamides
US6489363B2 (en) *	2000-10-11	2002-12-03	Cephalon, Inc.	Pharmaceutical solutions of modafinil compounds
US6344215B1 (en)	2000-10-27	2002-02-05	Eurand America, Inc.	Methylphenidate modified release formulations
US7141555B2 (en)	2000-12-19	2006-11-28	Cephalon, Inc.	Modafinil compound and cyclodextrin mixtures
KR100911779B1 (ko)	2001-05-25	2009-08-12	세파론, 인코포레이티드	모다피닐을 포함하는 고형 제약 제제
GB0117618D0 (en)	2001-07-19	2001-09-12	Phoqus Ltd	Pharmaceutical dosage form
US7229644B2 (en) *	2002-05-23	2007-06-12	Cephalon, Inc.	Pharmaceutical formulations of modafinil
US20040116532A1 (en)	2002-09-13	2004-06-17	Craig Heacock	Pharmaceutical formulations of modafinil

2004
- 2004-09-17 AR ARP040103336A patent/AR046410A1/es unknown
- 2004-09-17 US US10/944,528 patent/US8153159B2/en not_active Expired - Fee Related
- 2004-09-20 NZ NZ545573A patent/NZ545573A/en not_active IP Right Cessation
- 2004-09-20 EA EA200600590A patent/EA011400B1/ru not_active IP Right Cessation
- 2004-09-20 AT AT04788862T patent/ATE448780T1/de not_active IP Right Cessation
- 2004-09-20 CA CA2536666A patent/CA2536666C/en not_active Expired - Fee Related
- 2004-09-20 KR KR1020067005361A patent/KR20060117910A/ko not_active Ceased
- 2004-09-20 JP JP2006527123A patent/JP5138932B2/ja not_active Expired - Fee Related
- 2004-09-20 TW TW093128394A patent/TWI344840B/zh not_active IP Right Cessation
- 2004-09-20 MY MYPI20043844A patent/MY144755A/en unknown
- 2004-09-20 WO PCT/US2004/030815 patent/WO2005027890A1/en not_active Ceased
- 2004-09-20 DE DE602004024220T patent/DE602004024220D1/de not_active Expired - Lifetime
- 2004-09-20 ES ES04788862T patent/ES2336215T3/es not_active Expired - Lifetime
- 2004-09-20 AU AU2004274017A patent/AU2004274017B2/en not_active Ceased
- 2004-09-20 BR BRPI0414299-3A patent/BRPI0414299A/pt not_active IP Right Cessation
- 2004-09-20 EP EP04788862A patent/EP1670447B1/de not_active Expired - Lifetime
- 2004-09-20 MX MXPA06003125A patent/MXPA06003125A/es active IP Right Grant
2006
- 2006-02-14 IL IL173738A patent/IL173738A/en not_active IP Right Cessation
- 2006-02-23 IS IS8327A patent/IS2787B/is unknown
- 2006-02-28 NO NO20060964A patent/NO20060964L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EA200600590A1 (ru)	2006-08-25
IL173738A (en)	2012-07-31
EA011400B1 (ru)	2009-02-27
JP2007518696A (ja)	2007-07-12
JP5138932B2 (ja)	2013-02-06
IS2787B (is)	2012-06-15
WO2005027890A1 (en)	2005-03-31
IS8327A (is)	2006-02-23
EP1670447B1 (de)	2009-11-18
KR20060117910A (ko)	2006-11-17
DE602004024220D1 (de)	2009-12-31
CA2536666C (en)	2012-06-19
AU2004274017B2 (en)	2010-07-08
ATE448780T1 (de)	2009-12-15
HK1089697A1 (en)	2006-12-08
EP1670447A1 (de)	2006-06-21
CA2536666A1 (en)	2005-03-31
MY144755A (en)	2011-10-31
NZ545573A (en)	2010-02-26
US20050095294A1 (en)	2005-05-05
BRPI0414299A (pt)	2006-11-14
TWI344840B (en)	2011-07-11
AR046410A1 (es)	2005-12-07
MXPA06003125A (es)	2006-06-20
IL173738A0 (en)	2006-07-05
US8153159B2 (en)	2012-04-10
ES2336215T3 (es)	2010-04-09
AU2004274017A1 (en)	2005-03-31
TW200520748A (en)	2005-07-01

Legal Events

Date	Code	Title	Description
2016-04-18	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20060964L (no)	2006-04-18	Farmasoytiske sammensetninger med midifisert frigjoring av modafinil
DK3219705T3 (da)	2020-04-14	Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid
HRP20080564T3 (hr)	2009-02-28	Dihidrotetrabenazini i farmaceutski pripravci koji ih sadrže
NO2014009I2 (no)	2016-08-01	Forbindelser, farmasøytiske sammensetninger og anvendelser derav, samt fremgangsmåte for å fremstille nevnte forbindelser
DK1206474T3 (da)	2004-10-04	Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
LTPA2018502I1 (lt)	2018-03-12	Per burną vartojamos kladribino kompozicijos
NO20052058D0 (no)	2005-04-27	Behandling av influensa.
NO20071078L (no)	2007-04-26	Antivirale forbindelser
NO20070866L (no)	2007-04-13	Antivirale forbindelser.
WO2005000860A3 (en)	2005-07-21	Compositions and methods for treatment of disease with acetylated disaccharides
NO20082547L (no)	2008-09-22	Orale formuleringer omfattende tigecycline
NO20033618D0 (no)	2003-08-14	Ftalayinon-piperidino-derivater som PDE-4-inhibitorer
CL2007001838A1 (es)	2008-02-08	Compuestos derivados de 4-oxoquinolina; composicion farmaceutica; y uso del compuesto para la produccion de un agente anti-vih.
CL2007002380A1 (es)	2008-01-18	Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
NO20051281D0 (no)	2005-03-11	Sammensetning for anrikning av naeringsmidler
NO20043937L (no)	2005-03-23	Anvendelse av vitamin D sammensetninger
DK1458413T3 (da)	2009-11-23	Farmaceutiske sammensætninger på b asis af azetidin-derivater
IS6960A (is)	2003-09-18	Fenýl heterósýklýl eter afleiður sem serótónín endurupptökuhindrar
DK1475379T3 (da)	2007-09-03	Anvendelse af scopinesterderivater til fremstilling af lægemidler
EA200300727A1 (ru)	2004-02-26	Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
DK1687297T3 (da)	2014-09-22	Triazindimerer til behandling af autoimmunsygdomme
DK1658062T3 (da)	2010-05-31	Alfa-aminoamid-derivater anvendelige som anti-inflammatoriske midler
NO20052471D0 (no)	2005-05-23	Fremgangsmate for fremstilling av 3-metyltiopropanal.
DK1511724T3 (da)	2014-06-16	Fremgangsmåde til fremstilling af thioalkylaminderivater
ATE450273T1 (de)	2009-12-15	Proliferationshemmendes arzneimittel